Related Experiment Video
Updated: Mar 18, 2026

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
Caspase-3 in serum predicts outcome after aneurysmal subarachnoid hemorrhage
Jie Wang1, Jian-Feng Wang1, Xiao-Ming Hu1
1Department of Neurosurgery, Taizhou Hospital of Zhejiang Province, 150 Ximen Street, Linhai 317000, PR China.
Insights
Elevated serum caspase-3 activities correlate with aneurysmal subarachnoid hemorrhage (aSAH) severity and poor prognosis. These caspase-3 levels can predict outcomes, offering a potential biomarker for aSAH patients.
Area of Science:
- Biomarkers in Neurology
- Apoptosis Research
- Neurocritical Care
Background:
- Caspase-3 is a key enzyme in apoptosis, making it a potential indicator of cellular damage.
- Aneurysmal subarachnoid hemorrhage (aSAH) is a critical neurological condition with significant morbidity and mortality.
- Understanding markers of disease severity and prognosis in aSAH is crucial for patient management.
Purpose of the Study:
- To investigate the temporal changes in serum caspase-3 activity following aSAH.
- To analyze the relationship between serum caspase-3 activity and the severity of aSAH.
- To evaluate the predictive value of serum caspase-3 activity for patient outcomes after aSAH.
Main Methods:
- Serum caspase-3 activities were measured in 118 controls and 118 aSAH patients at various time points (admission, days 1, 2, 3, 5, 7).
- Comparisons were made based on time to blood sampling, World Federation of Neurological Surgeons (WFNS) scores, and modified Fisher scores.
- Six-month outcomes were assessed using the Glasgow Outcome Scale (GOS).
Main Results:
- Serum caspase-3 activities were significantly elevated in aSAH patients compared to controls, peaking on day 3 post-hemorrhage.
- Higher caspase-3 levels were observed in patients with unfavorable outcomes (GOS 1-3), correlating with WFNS and modified Fisher scores.
- Admission and day 3 caspase-3 activities independently predicted poor outcomes, even after adjusting for age and severity scores.
Conclusions:
- Increased serum caspase-3 activity is strongly associated with aSAH severity.
- Serum caspase-3 activity serves as a valuable prognostic marker for aSAH.
- Caspase-3 warrants further investigation as a potential therapeutic target or diagnostic tool in aSAH.
Background:
Caspase-3 represents a promising marker of apoptosis. This study was designed to investigate the serial change of serum caspase-3 activities and analyze the relationships between caspase-3 activities and the severity and prognosis of aneurysmal subarachnoid hemorrhage (aSAH).
Methods:
We determined serum caspase-3 activities of 118 controls at study entry and 118 patients at admission and at days 1, 2, 3, 5 and 7 after aSAH. Activities were compared with regard to (i) time interval between onset of symptoms and blood sampling, (ii) stroke severity quantified by World Federation of Neurological Surgeons (WFNS) scores and modified Fisher scores and (iii) 6-month outcome.
Results:
Serum caspase-3 activities were increased after aSAH, peaked at day 3, gradually decreased afterwards, and substantially were higher in patients than in controls. Caspase-3 activities were higher in patients suffering from death or an unfavorable outcome (Glasgow Outcome Scale score of 1-3), had close relation to WFNS scores and modified Fisher scores, and possessed high areas under receiver operating characteristic curve. Moreover, caspase-3 activities at admission and at day 3 predicted poor outcome independently of age, WFNS scores and modified Fisher scores.
Conclusion:
Increased serum caspase-3 activities are highly associated with the severity and prognosis after aSAH.
Related Concept Videos
Aneurysm III: Interprofessional Care
Caspases
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies

